Medpace is a clinical contract research organization that provides outsourced drug and device development services, managing clinical trials for biopharmaceutical and medical-device companies.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Ancora | 40 | Holds (flat) | 42 | $22,243 | 0.0% |
| François Rochon / Giverny | 67 | Trimmed -1% | 253,931 | $134,479,318 | 4.5% |
| Terry Smith / Fundsmith | 62 | Trimmed -16% | 52,372 | $27,735,687 | 0.2% |
| Bridgewater | 56 | Trimmed -62% | 15,605 | $8,264,252 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-05-15 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-05-15 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-02-26 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-01-29 | David J. Taylor OH02 | BUY | $1,001 - $15,000 | PTR |
| 2026-01-16 | David J. Taylor OH02 | SELL | $1,001 - $15,000 | PTR |
| 2026-01-15 | Gilbert Cisneros CA31 | SELL | $15,001 - $50,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.